Search results for "Statu"

showing 10 items of 2961 documents

Association Between Physical Activity and Odds of Chronic Conditions Among Workers in Spain

2020

Introduction:\ud \ud Prevention of chronic conditions is a major public health challenge, and achieving minimum recommended levels of physical activity aids in reaching this objective. The aim of our study was to investigate whether levels of physical activity were associated with the prevalence of common chronic conditions among the Spanish workforce.\ud \ud Methods:\ud \ud We retrieved data from the Spanish National Health Survey 2017 (N = 9,695) in which the mean age of participants was 44.4 (standard deviation, 10.4 y), and 47.4% were women. Workers self-reported a set of 6 chronic conditions (ie, chronic low-back pain, chronic neck pain, diabetes, hypertension, depression, and anxiety)…

AdultMalemedicine.medical_specialtyHealth StatusLogistic regression01 natural sciencesOddsBody Mass Index03 medical and health sciences0302 clinical medicineDiabetes mellitusmedicineOdds RatioPrevalenceHumans030212 general & internal medicine0101 mathematicsExerciseDepression (differential diagnoses)Original Researchbusiness.industryHealth PolicyPublic health010102 general mathematicsPublic Health Environmental and Occupational HealthOdds ratioMiddle Agedmedicine.diseaseHealth SurveysCross-Sectional StudiesSpainChronic DiseaseAnxietyFemalemedicine.symptombusinessBody mass indexDemography
researchProduct

Causal symptom attributions in somatoform disorder and chronic pain.

2009

Abstract Objective Somatoform disorders (SFD) are defined by symptoms that lack medical explanation. This study examined the type and pattern of patients' causal attributions using a new semistructured interview technique Methods The Causal Attributions Interview allows to assess and weigh 15 common explanations of physical symptoms. Attributions given by 79 patients with SFD were compared with those obtained from 187 chronic pain patients. Results The test–retest reliabilities of the interview-elicited attributions were satisfactory to good. SFD patients attributed most of their symptoms to mental/emotional problems (46.9%) and somatic disease (41.1%), while the pain sample preferred physi…

AdultMalemedicine.medical_specialtyHealth StatusPainDiseaseTime pressureSeverity of Illness IndexInterviews as TopicSurveys and QuestionnairesSeverity of illnessmedicineHumansPsychiatrySomatoform DisordersDepression (differential diagnoses)Internal-External ControlPsychiatric Status Rating ScalesChronic painReproducibility of ResultsMiddle AgedPatient Acceptance of Health Caremedicine.diseaseCausalityPsychiatry and Mental healthClinical PsychologyChronic DiseaseQuality of LifeFemalePsychologyAttributionSomatizationJournal of psychosomatic research
researchProduct

Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.

1984

Three-hour cortisol-profiles and cortisol responses to a 1 mg dose of dexamethasone were recorded in 31 depressed patients and nine controls. The data indicate that the likelihood of detecting non-suppressible cortisol concentrations after dexamethasone is significantly increased in depressed patients with a hypersecretion of cortisol. However, a considerable subsample of normosecretors shows abnormal DST results. Conversely, hypersecretion is often associated with dexamethasone suppression. In this study a 1 mg-DST did not reflect the adrenocortical activity with ultimate accuracy. Therefore any attempts which correlate psychopathological or biological data with pituitary-adrenal activity …

AdultMalemedicine.medical_specialtyHydrocortisoneDexamethasoneInternal medicinemedicineHumansCircadian rhythmDexamethasoneAgedPsychiatric Status Rating ScalesDepressive DisorderBiological activityMiddle AgedCircadian RhythmPsychiatry and Mental healthSleep deprivationDexamethasone suppressionEndocrinologyDexamethasone suppression testFemalemedicine.symptomBiological psychiatryPsychologyPsychopathologymedicine.drugActa psychiatrica Scandinavica
researchProduct

Computerized brain tomography measures compared with spontaneous and suppressed plasma cortisol levels in major depression.

1989

We determined brain density and ventricular measurements with computerized tomography (CT) in 33 depressed patients and compared the results with basal plasma cortisol and its suppressibility by dexamethasone. Mean plasma cortisol was positively related to elevated ventricular brain ratio (VBR). No association could be found between dexamethasone suppression test (DST) status and VBR or any other CT parameter. Elevated plasma cortisol levels and increased VBRs were positively correlated with total scores on the Brief Psychiatric Rating Scale, the Global Assessment Scale and the Bech-Rafaelsen Melancholia Scale, but they were not significantly correlated with total score on the Hamilton Anxi…

AdultMalemedicine.medical_specialtyHydrocortisoneEndocrinology Diabetes and MetabolismDexamethasoneCerebral VentriclesBasal (phylogenetics)EndocrinologyInternal medicineMelancholiaBrief Psychiatric Rating ScalemedicineHumansBiological PsychiatryDexamethasoneDepression (differential diagnoses)HydrocortisonePsychiatric Status Rating ScalesDepressive DisorderEndocrine and Autonomic SystemsBrainMiddle AgedVentricular-brain ratioPsychiatry and Mental healthEndocrinologyDexamethasone suppression testFemalemedicine.symptomPsychologyTomography X-Ray Computedmedicine.drugPsychoneuroendocrinology
researchProduct

Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studie…

1993

The effects of the optically active enantiomers of oxaprotiline (OXP), R(-) OXP and S(+) OXP, on depressive symptomatology and the sleep EEG were investigated in two separate exploratory studies. In addition, the neuroendocrine profile of both compounds was characterized in normal controls. In the patients treated with a daily oral dose of 150 mg S(+) OXP we found a Hamilton depression score that decreased from 29.1 +/- 1.8 (SEM) on day 0 to 14.7 +/- 3.2 on day 28 (P0.01). Six patients were judged to be full responders (HAMD score 0-7 points), three were improved (HAMD score 8-15) and four were nonresponders (HAMD score16). The therapeutic effect achieved with 150 mg R(-) OXP daily was less…

AdultMalemedicine.medical_specialtyHydrocortisoneSleep REMchemistry.chemical_compoundNorepinephrineInternal medicineHamdmedicineHumansPharmacology (medical)SecretionTestosteroneBiological PsychiatryTestosteroneAgedPharmacologyPsychiatric Status Rating ScalesDepressive DisorderNeurosecretionPenile ErectionTherapeutic effectOxaprotilineElectroencephalographyStereoisomerismMiddle AgedProlactinAntidepressive AgentsProlactinPsychiatry and Mental healthEndocrinologyNeurologychemistryMaprotilineGrowth HormoneEndogenous depressionFemaleNeurology (clinical)EnantiomerPsychologySleepEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer.

2020

Abstract Purpose Surgical complications such as hypoparathyroidism (HPT) or vocal cord palsy are seldom assessed when the quality of life (QOL) in thyroid cancer patients is investigated. The aim of this study was to measure the QOL difference in thyroid cancer survivors with and without HPT. Methods Participants for this analysis were enrolled in 13 countries from a study that pilot-tested a thyroid cancer–specific QOL instrument. They were included if they had been diagnosed with thyroid cancer at least 9 months previously. QOL was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30) and some items on HPT symptoms…

AdultMalemedicine.medical_specialtyHypoparathyroidismEndocrinology Diabetes and MetabolismHealth StatusClinical BiochemistryPilot ProjectsBiochemistryEndocrinologyPostoperative ComplicationsQuality of lifeCancer SurvivorsInternal medicineSurveys and QuestionnairesMedicineHumansIn patientThyroid NeoplasmsThyroid cancerAgedbusiness.industryBiochemistry (medical)ThyroidCancerMiddle Agedmedicine.diseasehumanitiesmedicine.anatomical_structureEndocrinologyCross-Sectional StudiesHypoparathyroidismMann–Whitney U testQuality of LifeFemalebusinessAfter treatmentThe Journal of clinical endocrinology and metabolism
researchProduct

Impaired anatomical connectivity and related executive functions: differentiating vulnerability and disease marker in bipolar disorder.

2012

Background Bipolar 1 disorder (BD1) has been associated with impaired set shifting, increased risk taking, and impaired integrity of frontolimbic white matter. However, it remains unknown to what extent these findings are related to each other and whether these abnormalities represent risk factors or consequences of the illness. Methods We addressed the first question by comparing 19 patients with BD1 and 19 healthy control subjects (sample 1) with diffusion tensor imaging, the Intra-Extra Dimensional Set Shift Task, and the Cambridge Gambling Task. The second question we approached by applying the same protocol to 22 healthy first-degree relatives of patients with BD1 and 22 persons withou…

AdultMalemedicine.medical_specialtyInternal capsuleBipolar DisorderAdolescentStatistics as TopicUncinate fasciculusAudiologyNeuropsychological TestsCorpus callosumNerve Fibers MyelinatedCorpus CallosumWhite matterExecutive FunctionYoung AdultFractional anisotropymedicineHumansFamilyBipolar disorderFirst-degree relativesPsychiatryBiological PsychiatryPsychiatric Status Rating ScalesCognitive flexibilityBrainMiddle Agedmedicine.diseasemedicine.anatomical_structureDiffusion Magnetic Resonance ImagingAnisotropyFemalePsychologyCognition DisordersBiological psychiatry
researchProduct

Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follo…

2019

BACKGROUND: Scarce research has focused on Visual Memory (VM) deficits as a possible neurocognitive endophenotype of bipolar disorder (BD). The main aim of this longitudinal, family study with healthy controls was to explore whether VM dysfunction represents a neurocognitive endophenotype of BD. METHODS: Assessment of VM by Rey-Osterrieth Complex Figure Test (ROCF) was carried out on a sample of 317 subjects, including 140 patients with BD, 60 unaffected first-degree relatives (BD-Rel), and 117 genetically-unrelated healthy controls (HC), on three occasions over a 5-year period (T1, T2, and T3). BD-Rel group scores were analyzed only at T1 and T2. RESULTS: Performance of BD patients was sig…

AdultMalemedicine.medical_specialtyLongitudinal study5 year follow upClinical variablesBipolar DisorderAdolescentEndophenotypesHealth StatusDiseaseAudiologyNeuropsychological TestsFamily Study03 medical and health sciencesYoung Adult0302 clinical medicineCognitionVisual memoryMedicineLongitudinal StudyHumansBipolar disorderLongitudinal StudiesNeurocognitionAgedMemory Disordersbusiness.industryMiddle Agedmedicine.diseaseFamily study030227 psychiatryVisual MemoryPsychiatry and Mental healthClinical PsychologyEndophenotypeEndophenotypeFemaleLongitudinal studyVisual memorybusinessNeurocognitive030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

The relationship between the dietary inflammatory index (DII®) and incident depressive symptoms: A longitudinal cohort study

2018

Abstract Background Diet is a common source of inflammation, and inflammation is associated with depression. We examined the association between the dietary inflammatory index (DII®), a validated measure of inflammatory potential of the diet, and risk of depression in a cohort of older North American adults. Methods This longitudinal study, with a follow-up of 8 years, included 3648 participants (1577 males, 2071 females; mean age: 60.6 years) with/at risk of knee osteoarthritis. DII® scores were calculated using the validated Block Brief 2000 Food-Frequency Questionnaire. Center for Epidemiological Studies Depression-20 scale was used to define depressive symptoms. The relationship between…

AdultMalemedicine.medical_specialtyLongitudinal studyNeuroimmunologyOld ageDiet SurveysCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologyHumansMedicineLongitudinal Studies030212 general & internal medicineHealth behaviorDepression (differential diagnoses)AgedProportional Hazards ModelsInflammationPsychiatric Status Rating ScalesDepressionbusiness.industryIncidenceIncidence (epidemiology)Hazard ratioConfoundingDepression Health behavior Neuroimmunology Old ageMiddle AgedDietPsychiatry and Mental healthClinical PsychologyQuartileCohortFemalebusiness030217 neurology & neurosurgeryDepression; Health behavior; Neuroimmunology; Old age; Adult; Aged; Cohort Studies; Depression; Diet; Diet Surveys; Female; Follow-Up Studies; Humans; Incidence; Inflammation; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Psychiatric Status Rating ScalesFollow-Up StudiesJournal of Affective Disorders
researchProduct

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.

2014

Objective: The objective of this paper is to identify clinical or magnetic resonance imaging (MRI) predictors of long-term clinical progression in a large cohort of multiple sclerosis (MS) patients. Methods: A total of 241 relapsing–remitting (RR) MS patients were included in a nine-year follow-up (FU) study. The reference MRIs were acquired at baseline (BL) as part of a multicenter, cross-sectional, clinical-MRI study. Volumetric MRI metrics were measured by a fully automated, operator-independent, multi-parametric segmentation method. Clinical progression was evaluated as defined by: conversion from RR to secondary progressive (SP) disease course; progression of Expanded Disability Status…

AdultMalemedicine.medical_specialtyMagnetic resonance imaging follow-up multiple sclerosis clinical predictors gray matter atrophypredictormultiple sclerosisDisease courseDisability EvaluationMultiple Sclerosis Relapsing-RemittingInternal medicinefollow-upmedicineHumansSecondary progressiveExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosisDisease progressionFollow up studiesMagnetic resonance imagingclinical predictorsMiddle Agedmedicine.diseaseMagnetic Resonance Imaginggray matter atrophyCross-Sectional StudiesNeurologymultiple sclerosiDisease ProgressionSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessNuclear medicineClinical progressionMRIFollow-Up StudiesMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct